AS Natural History Study Celebrates 20 Years!
Celebrating 20 years of the Angelman Syndrome Natural History Study—decades of data, driven by families and researchers, that continues to fuel discovery and progress.
Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career Scientists
FAST partners with ASGCT to fund up to three $100,000 Career Development Awards, recruiting early-career scientists to advance neuron-targeted gene and cell therapies for Angelman syndrome.”
FAST Speaks at the 2025 MENA Congress for Rare Diseases
FAST representatives Amelia Beatty and Ellen Koekoeckx presented at the MENA Congress for Rare Diseases in Abu Dhabi, highlighting the Angelman syndrome therapeutic pipeline and connecting with regional families and researchers.